Difluorocarbene radiosynthesis
US-2024383827-A1 · Nov 21, 2024 · US
Small molecule xanthine oxidase inhibitors and methods of use
US8987337B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-8987337-B2 |
| Application number | US-201414339428-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 23, 2014 |
| Priority date | Dec 7, 2012 |
| Publication date | Mar 24, 2015 |
| Grant date | Mar 24, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
Small molecule xanthine oxidase inhibitors are provided, as well as methods for their use in treating gout or hyperuricemia.
First claim
Opening claim text (preview).
What is claimed is: 1. A method for inhibiting xanthine oxidase in a patient, wherein the method comprises administering to the patient a therapeutically effective amount of a compound selected from the group consisting of compound I and II: or a pharmaceutically acceptable salt thereof. 2. A method for inhibiting xanthine oxidase in a patient, where…
Assignees
Inventors
Classifications
Chemistry & Metallurgy · mapped topic
- A61K31/11Primary
Human Necessities · mapped topic
Human Necessities · mapped topic
- C07C205/44Primary
Chemistry & Metallurgy · mapped topic
Human Necessities · mapped topic
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US8987337B2 cover?
- Small molecule xanthine oxidase inhibitors are provided, as well as methods for their use in treating gout or hyperuricemia.
- Who is the assignee on this patent?
- Baylor College Medicine
- What technology area does this patent fall under?
- Primary CPC classification A61K31/11. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Mar 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).